Browsing Tag
TNX-102 SL
2 posts
Tonix Pharmaceuticals (NASDAQ: TNXP) surges 9.5% as fibromyalgia data and vaccine platform boost investor confidence
Tonix Pharmaceuticals stock surged 9.5% after new fibromyalgia and mpox vaccine data. Find out what’s driving investor optimism and what comes next.
Tonix Pharmaceuticals stock up over 20%: Can TNX-102 SL and TNX-1700 fuel a turnaround in 2025?
Tonix Pharmaceuticals surged 21% despite deep losses, as retail traders bet on TNX-102 SL’s FDA nod and cancer pipeline momentum. Read the full story.